| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.9 |